Brainstorm Cell Therapeutics Share Price Today
(NASDAQ: BCLI)
Brainstorm Cell Therapeutics share price is $1.58 & ₹137.41 as on 6 Mar 2025, 2.30 'hrs' IST
$1.58
▲
0.08
(5.05%)
Market is closed - opens 8 PM, 06 Mar 2025
View live Brainstorm Cell Therapeutics share price in Dollar and Rupees. Guide to invest in Brainstorm Cell Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Brainstorm Cell Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Brainstorm Cell Therapeutics share price movements
- Today's Low: $1.55Today's High: $1.70
1.9%
Downside
Day's Volatility :8.82%
Upside
7.05%
- 52 Weeks Low: $1.0552 Weeks High: $11.89
33.54%
Downside
52 Weeks Volatility :91.17%
Upside
86.71%
Brainstorm Cell Therapeutics (BCLI) Returns
Brainstorm Cell Therapeutics (BCLI) Key Statistics
in dollars & INR
How to invest in Brainstorm Cell Therapeutics Stock (BCLI) from India?
It is very easy for Indian residents to invest directly in Brainstorm Cell Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Brainstorm Cell Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Brainstorm Cell Therapeutics or BCLI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Brainstorm Cell Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Brainstorm Cell Therapeutics shares which would translate to 0.550 fractional shares of Brainstorm Cell Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Brainstorm Cell Therapeutics, in just a few clicks!
Returns in Brainstorm Cell Therapeutics (BCLI) for Indian investors in Rupees
The Brainstorm Cell Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
Investment Value
₹1,00,000
Brainstorm Cell Therapeutics investment value today
Current value as on today
₹36,947
Returns
Returns from Brainstorm Cell Therapeutics Stock
Dollar Returns
₹4,963 (+4.96%)
Indian investors sentiment towards Brainstorm Cell Therapeutics (BCLI)
Global Institutional Holdings in Brainstorm Cell Therapeutics
CALDWELL SUTTER CAPITAL INC
2.75%
Vanguard Group Inc
1.38%
Geode Capital Management, LLC
0.92%
BlackRock Inc
0.44%
HRT FINANCIAL LLC
0.35%
TWO SIGMA SECURITIES, LLC
0.20%
Analyst Recommendation on Brainstorm Cell Therapeutics
Sell
0%Buy
50%Hold
50%Sell
Based on 6 Wall street analysts offering stock ratings for Brainstorm Cell Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Brainstorm Cell Therapeutics Stock (BCLI)
What analysts predicted
Upside of 814.56%
Target:
$14.45
Current:
$1.58
Insights on Brainstorm Cell Therapeutics Stock (Ticker Symbol: BCLI)
Price Movement
In the last 6 months, BCLI stock has moved down by -63.8%Increasing Revenue
Revenue is up for the last 2 quarters, -569.0K → 365.0K (in $), with an average increase of 255.9% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -2.54M → -2.70M (in $), with an average decrease of 6.6% per quarterBCLI vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 133.5%BCLI vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 144.3%
Brainstorm Cell Therapeutics Technicals Summary
Sell
Neutral
Buy
Brainstorm Cell Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Brainstorm Cell Therapeutics (BCLI) Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -18.26% | -63.8% | -69.58% | -96.57% | -98.63% |
 | 1.3% | -41.29% | -30.51% | 9.2% | 42.38% |
 | 15.19% | 34.31% | 61.3% | 43.16% | 68.1% |
 | 3.37% | 3.77% | 18.06% | 106.43% | 121.36% |
 | -11.52% | -3.4% | 62.32% | 49.04% | 120.93% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 0.0 | -2.1 | -11.22 | -2.16 | NA | -1.14 |
| 17.85 | 17.85 | 1.03 | 43.09 | 0.16 | 0.07 | 0.01 | 273.57 |
| NA | NA | NA | 1.43 | -0.19 | -0.06 | NA | 31.22 |
| 32.84 | NA | 1.33 | 18.07 | -0.03 | 0.13 | NA | 63.87 |
| NA | NA | -0.49 | 0.57 | -15.01 | -0.03 | NA | 0.52 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Sell | $8.6M | -98.63% | NA | 0.0% |
| Buy | $74.9B | 42.38% | 17.85 | 31.07% |
| NA | $28.5B | 68.1% | NA | -16.92% |
| Buy | $124.1B | 121.36% | 32.84 | -4.86% |
| Buy | $31.5B | 120.93% | NA | -12.37% |
About Brainstorm Cell Therapeutics
Management People of Brainstorm Cell Therapeutics
Important FAQs about investing in BCLI Stock from India :
What is Brainstorm Cell Therapeutics share price today?
Brainstorm Cell Therapeutics share price today stands at $1.58, Open: $1.55 ; Previous Close: $1.50 ; High: $1.70 ; Low: $1.55 ; 52 Week High: $11.89 ; 52 Week Low: $1.05.
The stock opens at $1.55, after a previous close of $1.50. The stock reached a daily high of $1.70 and a low of $1.55, with a 52-week high of $11.89 and a 52-week low of $1.05.
Can Indians buy Brainstorm Cell Therapeutics shares?
Yes, Indians can invest in the Brainstorm Cell Therapeutics (BCLI) from India.
With INDmoney, you can buy Brainstorm Cell Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Brainstorm Cell Therapeutics at zero transaction cost.
How can I buy Brainstorm Cell Therapeutics shares from India?
It is very easy to buy Brainstorm Cell Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Brainstorm Cell Therapeutics (BCLI) be purchased?
Yes, you can buy fractional shares of Brainstorm Cell Therapeutics with INDmoney app.
What are the documents required to start investing in Brainstorm Cell Therapeutics stocks?
To start investing in Brainstorm Cell Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Brainstorm Cell Therapeutics Stock (BCLI)?
Today’s highest price of Brainstorm Cell Therapeutics (BCLI) is $1.70.
Today’s lowest price of Brainstorm Cell Therapeutics (BCLI) is $1.55.
What is today's market capitalisation of Brainstorm Cell Therapeutics?
What is the 52 Week High and Low Range of Brainstorm Cell Therapeutics Stock (BCLI)?
52 Week High
$11.89
52 Week Low
$1.05
What are the historical returns of Brainstorm Cell Therapeutics (BCLI)?
1 Month Returns
-18.26%
3 Months Returns
-63.8%
1 Year Returns
-69.58%
5 Years Returns
-98.63%
Who is the Chief Executive Officer (CEO) of Brainstorm Cell Therapeutics ?
Discover More
Ft Cboe Vest Us Equity Moderate Buffer Etf - Apr$37.83
+0.43%
Apollomics Inc$6.50
-0.55%
Toews Agility Shares Managed Risk Etf$32.76
+0.77%
Blackrock Corporate High Yield Fund Inc$9.79
-0.1%
Surgepays Inc$1.23
+8.85%
Primis Financial Corp$9.96
-1.58%
Blackrock Resources & Commod$8.84
+0.68%
Lemonade Inc$36.83
-1.29%
Grupo Aval Acciones Y Valores S.a.$3.03
+4.84%